Lv4
688 积分 2023-04-11 加入
P1.11.67 VEGFR1/PD-L1 CAR-T Cell Treatment of Solid Tumor-Derived Malignant Pleural Effusion/Ascites
8天前
已完结
Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence
23天前
已完结
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
28天前
已完结
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
29天前
已关闭
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
29天前
已完结
CAR-T therapy in solid tumors
1个月前
已完结
Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy
1个月前
已完结
A Multifunctional Aptamer Decorated Lipid Nanoparticles for the Delivery of EpCAM‐targeted CRISPR/Cas9 Plasmid for Efficacious In Vivo Tumor Regression
2个月前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
3个月前
已完结
Pancreatic Cancer-Associated Fibroblasts: Where do we go from here?
5个月前
已完结
皖公网安备34019202002308
